A revision and summary of injectable fillers

다국어 초록 (Multilingual Abstract)

Background: Injectable fillers are common and useful tools in aesthetic medicine for reconditioning, restoring, or recontouring the quality and structure of the corresponding skin and body parts. Various choices with different properties are available, each unique and with its own advantages and disadvantages, which result in diverse indications and applications. Moreover, improper use of fillers also leads to complications and drawbacks. Awareness of the risks and management of the adverse effects are important and brief ideas of those injectables are essential. Objective: This article provides a brief revision and summary of the common injectable fillers in terms of properties, functions, complications, and management. Methods: Peer-reviewed articles published from 1984 to 2017 were identified from PubMed and Google Scholar, and qualitatively reviewed with respect to concurrent common injectable materials. Results and conclusion: Knowledge of different injectables are important for proper application in different indications and safety of use. This article gives a brief revision.

목차 (Table of Contents)

• Introduction Materials and method Results and discussion Conclusion Conflicts of interest References

참고문헌 (Reference)

1 Gooderham M, "Use of hyaluronic acid for soft tissue augmentation of HIV-associated facial lipodystrophy" 31 : 104-108, 2005

2 Misiek DJ, "Soft tissue responses to hydroxylapatite particles of different shapes" 42 : 150-160, 1984

3 Dayan SH, "Soft tissue fillers and biofilms" 27 : 23-28, 2011

4 Friedman PM, "Safety data of injectable nonanimal stabilized hyaluronic acid gel for soft tissue augmentation" 28 : 491-494, 2002

5 Pecharki D, "Role of hyaluronidase in streptococcus intermedius biofilm" 154 : 932-938, 2008

6 Dumond P, "Pre-lethal anaphylaxis to carboxymethylcellulose confirmed by identification of specific IgE--review of the literature" 41 : 171-176, 2009

7 Moers-Carpi MM, "Polycaprolactone for the correction of nasolabial folds : a 24-month, prospective, randomized, controlled clinical trial" 39 (39): 457-463, 2013

8 Simamora P, "Poly-L-lactic acid : an overview" 5 : 436-440, 2006

9 Narins RS, "Minimizing adverse events associated with poly-L-lactic acid injection" 34 (34): S100-S104, 2008

10 Narins RS, "Minimizing adverse events associated with poly-L-lactic acid injection" 34 (34): S100-S104, 2008

11 Chong BF, "Microbial hyaluronic acid production" 66 : 341-351, 2005

12 Goisis M, "Injections in aesthetic medicine : atlas of full-face and full-body treatment" Springer 2014

13 Matarasso SL, "Hypersensitivity reaction to nonanimal stabilized hyaluronic acid" 55 : 128-131, 2006

14 Ferraz MP, "Hydroxyapatite nanoparticles : a review of preparation methodologies" 2 : 74-80, 2004

15 Drobeck HP, "Histologic observation of soft tissue responses to implanted, multifaceted particles and discs of hydroxylapatite" 42 : 143-149, 1984

16 Skrzypek E, "Granuloma as a complication of polycaprolactone-based dermal filler injection : ultrasound and histopathology studies" 21 : 65-68, 2019

17 Tzikas TL, "Evaluation of the radiance FN soft tissue filler for facial soft tissue augmentation" 6 : 234-239, 2004

18 Salles AG, "Evaluation of the poly-L-lactic acid implant for treatment of the nasolabial fold : 3-year follow-up evaluation" 32 : 753-756, 2008

19 McLoughlin CE, "Evaluation of innate, humoral and cell-mediated immunity in mice following in vivo implantation of electrospun polycaprolactone" 7 : 035015-, 2012

20 Lupton JR, "Cutaneous hypersensitivity reaction to injectable hyaluronic acid gel" 26 : 135-137, 2000

21 Palm MD, "Cosmetic use of poly-l-lactic acid : a retrospective study of 130patients" 36 : 161-170, 2010

22 Tippawan Siritientong, "Characteristics of Carboxymethyl Cellulose/Sericin Hydrogels and the Influence of Molecular Weight of Carboxymethyl Cellulose" 한국고분자학회 23 (23): 861-866, 2015

23 Yoshimura K, "Cellassisted lipotransfer for cosmetic breast augmentation : supportive use of adipose-derived stem/stromal cells" 32 : 48-55, 2008

24 Toyserkani NM, "Cell-assisted lipotransfer : a systematic review of its efficacy" 40 : 309-318, 2016

25 de Albuquerque GC, "Botulinum toxins, fillers and related substances. Clinical approaches and procedures in cosmetic dermatology" Springer 1-7, 2017

26 Heimowska A, "Biodegradation of poly(ε-caprolactone)in natural water environments" 19 : 120-126, 2017

27 Khan TT, "An anatomical analysis of the supratrochlear artery : considerations in facial filler injections and preventing vision loss" 37 : 203-208, 2017

28 Mastrokalos DS, "Allergic reaction to biodegradable interference poly-L-lactic acid screws after anterior cruciate ligament reconstruction with bone-patellar tendonbone graft" 24 : 732-733, 2008

29 Requena L, "Adverse reactions to injectable soft tissue fillers" 64 : 1-34, 2011

30 Sturm LP, "A systematic review of permanent and semipermanent dermal fillers for HIV-associated facial lipoatrophy" 23 : 699-714, 2009

31 Hevia O, "A retrospective review of calcium hydroxylapatite for correction of volume loss in the infraorbital region" 35 : 1487-1494, 2009

32 Narins RS, "A randomized study of the efficacy and safety of injectable poly-L-lactic acid versus human-based collagen implant in the treatment of nasolabial fold wrinkles" 62 : 448-462, 2010